We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
301
Illumina
ILMN
$29.4B
$4.95M 0.07%
18,235
+11,391
+166% +$2.9M
CTAS icon
302
Cintas
CTAS
$82.4B
$4.84M 0.07%
104,708
+48,284
+86% +$2.17M
DK icon
303
Delek US
DK
$3.87B
$4.84M 0.07%
96,558
+35,897
+59% +$1.78M
FPAC.U
304
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
$4.81M 0.07%
+471,700
New +$4.8M
SBLK icon
305
Star Bulk Carriers
SBLK
$3.14B
$4.77M 0.07%
370,616
+34,082
+10% +$434K
HYG icon
306
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$4.74M 0.07%
+55,693
New +$4.77M
XYL icon
307
Xylem
XYL
$28.5B
$4.72M 0.07%
+70,026
New +$5.08M
ALL icon
308
Allstate
ALL
$66.9B
$4.69M 0.07%
51,387
+24,964
+94% +$2.37M
PCTY icon
309
Paylocity
PCTY
$6.71B
$4.66M 0.07%
79,234
+69,234
+692% +$3.97M
DNB
310
DELISTED
Dun & Bradstreet
DNB
$4.63M 0.07%
+37,750
New +$4.59M
FBIN icon
311
Fortune Brands Innovations
FBIN
$6.12B
$4.59M 0.07%
+100,054
New +$4.85M
DCT
312
DELISTED
DCT Industrial Trust Inc.
DCT
$4.55M 0.07%
+68,253
New +$4.28M
WMB icon
313
Williams Companies
WMB
$90.5B
$4.52M 0.07%
166,746
+147,452
+764% +$3.89M
FRO icon
314
Frontline
FRO
$8.75B
$4.51M 0.07%
774,406
+662,138
+590% +$3.34M
USG
315
DELISTED
Usg
USG
$4.49M 0.07%
104,201
+61,573
+144% +$2.56M
HOME
316
DELISTED
At Home Group Inc.
HOME
$4.48M 0.07%
114,333
+107,733
+1,632% +$3.87M
GL icon
317
Globe Life
GL
$13.5B
$4.47M 0.07%
+54,962
New +$4.67M
DFS
318
DELISTED
Discover Financial Services
DFS
$4.37M 0.07%
+62,087
New +$4.55M
SAFM
319
DELISTED
Sanderson Farms Inc
SAFM
$4.36M 0.07%
+41,493
New +$4.5M
GLOG
320
DELISTED
GASLOG LTD
GLOG
$4.35M 0.07%
+227,700
New +$4.05M
WERN icon
321
Werner Enterprises
WERN
$2.54B
$4.35M 0.07%
+115,769
New +$4.3M
ALLY icon
322
Ally Financial
ALLY
$13.1B
$4.34M 0.06%
+165,155
New +$4.41M
DRI icon
323
Darden Restaurants
DRI
$22.5B
$4.33M 0.06%
+40,447
New +$3.7M
BRKR icon
324
Bruker
BRKR
$9.2B
$4.29M 0.06%
147,710
-12,870
-8% -$391K
EQT icon
325
EQT Corp
EQT
$33.2B
$4.26M 0.06%
141,927
-22,198
-14% -$619K

Similar funds

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.